---
figid: PMC9214595__etm-24-01-11413-g01
pmcid: PMC9214595
image_filename: etm-24-01-11413-g01.jpg
figure_link: /pmc/articles/PMC9214595/figure/f2-ETM-24-1-11413/
number: Figure 2
figure_title: ''
caption: 'Effects of TIIA on serum transaminase, lipid, TBIL and TBA levels in methionine
  choline deficiency diet-fed rats. (A) Serum transaminase levels in rats (ALT, NASH-F
  vs. control, P=0.001; and TIIA vs. NASH-F, P=0.008; AST, NASH-F vs. control, P=0.002;
  and TIIA vs. NASH-F, P=0.006). (B) Serum lipid levels in rats (TC, NASH-F vs. control,
  P=0.005; and TIIA vs. NASH-F, P=0.147; TG, NASH-F vs. control, P<0.001; and TIIA
  vs. NASH-F, P=0.074). (C) Serum TBIL and TBA levels in rats (TBIL, NASH-F vs. control,
  P<0.001; and TIIA vs. NASH-F, P<0.001; TBA, NASH-F vs. control, P<0.001; and TIIA
  vs. NASH-F, P=0.004). ##P<0.01; **P<0.01 (n=6). NASH-F, non-alcoholic steatohepatitis-related
  fibrosis; TIIA, tanshinone IIA; ALT, alanine aminotransferase; AST, aspartate aminotransferase;
  TC, total cholesterol; TG, triglycerides; TBIL, total bilirubin; TBA, total bile
  acid.'
article_title: Tanshinone IIA regulates the TGF-β1/Smad signaling pathway to ameliorate
  non-alcoholic steatohepatitis-related fibrosis.
citation: Lianjie Xu, et al. Exp Ther Med. 2022 Jul;24(1):486.
year: '2022'

doi: 10.3892/etm.2022.11413
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- hepatic fibrosis
- non-alcoholic steatohepatitis
- tanshinone IIA
- TGF-β1/Smad

---
